Likewise, the small molecule acriflavine, targeting the binding between MCT4 and its chaperone basigin, has been revealed to inhibit the growth and self-renewal potential of glioma neurospheres, especially under hypoxia [145]. This evidence concerns the gene SLC16A3 and central nervous system cancer.